Katexco Pharmaceuticals Corp.
|
|||
| Mailing Address: | #1305 - 1090 W. Georgia St. Vancouver, BC V6E 3V7 |
Head Office Address: | #1305 - 1090 W. Georgia St. Vancouver, BC V6E 3V7 |
| Contact Name: | N. DEMARE | Principal Regulator: | Non-Reporting Issuer |
| Business e-mail address: | ndemare@chasemgt.com | Short Form Prospectus Issuer: | No |
| Telephone Number: | 604 685-9316 | Reporting Jurisdictions: | Non-Reporting Issuer |
| Fax Number: | 604 683-1585 | Stock Exchange: | N/A |
| Date of Formation: | Mar 7 2018 | Stock Symbol: | |
| Jurisdiction Where Formed: | British Columbia | Auditor: | D&H Group LLP |
| Industry Classification: | consumer products - biotechnology/pharmaceuticals | General Partner: | |
| CUSIP Number: | Transfer Agent: | COMPUTERSHARE INVESTOR SERVICES INC. | |
| Financial Year-End: | Dec 31 | Size of Issuer (Assets): | Under $5,000,000 |
|
